- Previous Close
0.0000 - Open
0.0100 - Bid 0.0081 x --
- Ask 0.0120 x --
- Day's Range
0.0100 - 0.0100 - 52 Week Range
0.0100 - 0.0700 - Volume
10,000 - Avg. Volume
3,522 - Market Cap (intraday)
468,815 - Beta (5Y Monthly) 0.63
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0700 - Earnings Date Apr 7, 2025 - Apr 13, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Apr 2, 2018
- 1y Target Est
--
NovelStem International Corp., a development stage biotechnology holding company, focuses on development and commercialization of stem cell-based diagnostic technology for cancer treatments and to reduce resistance to chemotherapy. The company was formerly known as Hollywood Media Corp. and changed its name to NovelStem International Corp. in September 2018. NovelStem International Corp. was incorporated in 1993 and is headquartered in Boca Raton, Florida.
www.novelstem.com--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NSTM
View MorePerformance Overview: NSTM
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NSTM
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NSTM
View MoreValuation Measures
Market Cap
421.93k
Enterprise Value
4.68M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
35.16
Price/Book (mrq)
--
Enterprise Value/Revenue
390.34
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-51.40%
Return on Equity (ttm)
--
Revenue (ttm)
12k
Net Income Avi to Common (ttm)
-3.02M
Diluted EPS (ttm)
-0.0700
Balance Sheet and Cash Flow
Total Cash (mrq)
45.32k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-616.35k